Orthocell has entered an MOU to secure exclusive distribution rights for Marine Biomedical's innovative bone substitute PearlBone, and lift its stake in the company to 12 per cent.
21/10/2025 - 15:02
Orthocell to up stake in ‘groundbreaking’ pearl bone substitute
21/10/2025 - 15:02
